5 Hrs
Source:
الاقتصادية
الاقتصادية
Ready to play
Ready to play
Al-Dala Medical Company announced the completion of the sale of its 31.21% stake in Dr. Mohammed bin Rashed Al Faqih & Partners for an approximate cash amount of 498 million SAR. The sale aims to strengthen its financial position and support its expansion and acquisition plans. The transfer process was finalized after all conditions were met and regulatory approvals were obtained, with a reserve of 100 million SAR held as collateral to address potential issues. The deal is expected to have positive financial impacts on the company, including capital gains and reduced financing costs, without adversely affecting profitability in the upcoming period.
Notice: This Is an AI-Generated Summary
Comments (0)